/
/
/

Supha Pharmachem Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Sep 2025Jun 2025Mar 2025
₹111 Cr₹113 Cr₹264 Cr
₹3 Cr₹3 Cr₹66 L
₹114 Cr₹117 Cr₹265 Cr
₹104 Cr₹111 Cr₹265 Cr
₹11 Cr₹5 Cr₹20 L
₹19 L-₹37 L₹2 Cr
₹10 Cr₹6 Cr-₹1 Cr
₹9 Cr₹5 Cr-₹2 Cr

Share Price Live Stats

Open (₹)0.26
Volume (₹)23.17 L
High (₹)0.26
Upper Circuit0.26
Low (₹)0.24
Lower Circuit0.24
Prev Close0.25
52W High (₹)1.80
Price0.25
52W Low (₹)0.24

Share Market Cap & Key Ratios Overview

M.Cap (₹)22.05 Cr
Div. Yield (%)0.00
PE Ratio10.35
Debt to Equity26.01
Price to Book1.67
Book Value0.76
EPS (TTM)0.02
Face Value1.00
ROE (%)4.85

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
CPPLUS-ANSE
AEGISLOG-ANSE
PREMIERENE-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
SREEL-TNSE
SUPHA-ZNSE
LTP
1W Low
1W High
Market cap (₹)
2700+66.9 (2.54%)
2611
2734
3,67,901Cr
4108.35-77.7 (-1.86%)
4014
4619.10
54,443Cr
1406+17.9 (1.29%)
1366.10
1509.90
52,204Cr
910.6+15.6 (1.74%)
884.80
930.90
41,991Cr
391+10.9 (2.87%)
380
411.45
31,431Cr
451-17.75 (-3.79%)
445.40
481
14,906Cr
70.19-3.65 (-4.94%)
69.25
74.73
10,962Cr
363.5-1.8 (-0.49%)
359.05
385.40
8,419Cr
389+3.7 (0.96%)
379.55
406
4,782Cr
277.15+4.5 (1.65%)
277.15
284
654Cr
0.25-0.01 (-3.85%)
0.24
0.26
22Cr
Empty box

No content available